CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 18 filers reported holding CALLIDITAS THERAPEUTICS AB in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $42,509 | +1.0% | 2,328 | -12.3% | 0.00% | – |
Q2 2023 | $42,069 | +26.5% | 2,656 | +91.5% | 0.00% | – |
Q1 2023 | $33,246 | +36.0% | 1,387 | -3.5% | 0.00% | – |
Q4 2022 | $24,446 | +35.8% | 1,438 | +26.9% | 0.00% | – |
Q3 2022 | $18,000 | -76.3% | 1,133 | -73.6% | 0.00% | – |
Q2 2022 | $76,000 | +442.9% | 4,295 | +489.2% | 0.00% | – |
Q1 2022 | $14,000 | -79.7% | 729 | -73.5% | 0.00% | – |
Q4 2021 | $69,000 | +60.5% | 2,755 | +37.4% | 0.00% | – |
Q3 2021 | $43,000 | +43.3% | 2,005 | +97.9% | 0.00% | – |
Q2 2021 | $30,000 | +57.9% | 1,013 | +45.5% | 0.00% | – |
Q1 2021 | $19,000 | +850.0% | 696 | +908.7% | 0.00% | – |
Q2 2020 | $2,000 | – | 69 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Endurant Capital Management LP | 144,393 | $4,252,000 | 1.17% |
BVF INC/IL | 750,000 | $22,080,000 | 0.83% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 15,890 | $468,000 | 0.24% |
Vivo Capital, LLC | 62,306 | $1,835,000 | 0.08% |
Pentwater Capital Management LP | 50,000 | $1,473,000 | 0.01% |
NEXT Financial Group, Inc | 4,458 | $131,000 | 0.01% |
Advisory Services Network, LLC | 3,369 | $99,000 | 0.00% |
DEUTSCHE BANK AG\ | 71,531 | $2,107,000 | 0.00% |
JANE STREET GROUP, LLC | 7,216 | $211,000 | 0.00% |
UBS Group AG | 11 | $0 | 0.00% |